U.S. starts enrollment in trial testing Siga’s antiviral for monkeypox
(Reuters) – The National Institutes of Health (NIH) said on Friday it had started enrolling monkeypox patients in a late-stage study testing Siga Technologies Inc’s antiviral pill Tpoxx against the disease. The…
